Abrdn Healthcare Investors

Abrdn Healthcare Investors

Financial Services

NYSE:HQH · New York Stock Exchange

Market Cap $1.07B Beta 0.76 P/E (TTM) 4.1
$19.35 +1.63%

+$0.31 today

52W Low $15.09High $20.46

Vol 0.08M · Avg 0.14M

EPS (TTM)$4.72
Div Yield11.99%
Asset Management

Management

Put operating results in leadership context

Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.

Return Metrics

ROE, ROIC & ROA over time

Management

ROE

9.0%

avg 4.7%

ROIC

9.0%

avg 0.5%

ROA

9.0%

avg 4.7%

Analysis

ROE is currently the strongest return metric at 9.0% versus its period average of 4.7%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Management

Key executives, compensation & ownership

Management
NameTitleCompensationTenureAgeShares OwnedOwnership %

Daniel R. Omstead

Portfolio Manager73$178,268.560.31%

Frank T. Gentile

Senior Vice President of Research and Portfolio Manager64$0.00<0.01%

Christopher F. Brinzey

Senior Vice President of Research and Portfolio Manager$0.00<0.01%

Jason C. Akus

Vice President of Research and Portfolio Manager$0.00<0.01%

Insider Trading

SEC Form 4 transactions — last 12 months

Management

No insider transactions in the last 12 months.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr5yr3yr Fwd Est.
EPSN/AN/A-14.0%
N/A
RevenueN/AN/A+16.1%
N/A
Net IncomeN/AN/A-10.4%
N/A
EBITN/AN/AN/A
N/A

Analysis

Recent growth has been strongest in Revenue at +16.1% over three years.

Who manages HQH?

Abrdn Healthcare Investors (HQH) lists 4 active executives. The top listed executive is Daniel R. Omstead, Portfolio Manager.

Are HQH insiders buying or selling?

Recent insider activity shows net buying of $894,425.37.

Explore More

Continue the stock analysis

Jump to another research area for this company.